PTN
Price:
$21.5
Market Cap:
$559.12M
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and me...[Read more]
Industry
Biotechnology
IPO Date
1997-10-15
Stock Exchange
AMEX
Ticker
PTN
According to Palatin Technologies, Inc.’s latest financial reports and current stock price. The company's current ROE is 112.10%. This represents a change of -66.54% compared to the average of 335.07% of the last 4 quarters.
The mean historical ROE of Palatin Technologies, Inc. over the last ten years is 2.86%. The current 112.10% ROE has changed -96.08% with respect to the historical average. Over the past ten years (40 quarters), PTN's ROE was at its highest in in the June 2024 quarter at 7.40%. The ROE was at its lowest in in the June 2023 quarter at -7991.51%.
Average
2.86%
Median
174.87%
Minimum
-222.51%
Maximum
26.67%
Discovering the peaks and valleys of Palatin Technologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.10%
Maximum Annual ROE = 26.67%
Minimum Annual Increase = -645.61%
Minimum Annual ROE = -222.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | 362.30% | -98.64% |
| 2024 | 26.67% | 2.10% |
| 2023 | 1.21% | -645.61% |
| 2022 | -222.51% | 229.12% |
| 2021 | -67.61% | 142.18% |
| 2020 | -27.92% | -178.47% |
| 2019 | 35.58% | -61.16% |
| 2018 | 91.61% | -64.51% |
| 2017 | 258.13% | -12.22% |
| 2016 | 294.06% | -303.15% |
The current ROE of Palatin Technologies, Inc. (PTN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.42%
5-year avg
5.59%
10-year avg
2.86%
Palatin Technologies, Inc.’s ROE is less than Biophytis S.A. (129.31%), greater than Eiger BioPharmaceuticals, Inc. (-367.00%), less than Notable Labs, Ltd. (103.08%), greater than Novan, Inc. (-170.66%), greater than Aravive, Inc. (-306.06%), less than Fresh2 Group Limited (1.12%), greater than Affimed N.V. (-133.26%), less than Q32 Bio Inc. (580.22%), greater than Midatech Pharma plc (-63.03%), greater than VBI Vaccines Inc. (-258.99%),
| Company | ROE | Market cap |
|---|---|---|
| 129.31% | $2.61M | |
| -367.00% | $12.59M | |
| 103.08% | $2.39M | |
| -170.66% | $2.64M | |
| -306.06% | $2.95M | |
| 1.12% | $2.08M | |
| -133.26% | $2.98M | |
| 580.22% | $43.06M | |
| -63.03% | $1.98M | |
| -258.99% | $1.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palatin Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Palatin Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Palatin Technologies, Inc.'s ROE?
How is the ROE calculated for Palatin Technologies, Inc. (PTN)?
What is the highest ROE for Palatin Technologies, Inc. (PTN)?
What is the 3-year average ROE for Palatin Technologies, Inc. (PTN)?
What is the 5-year average ROE for Palatin Technologies, Inc. (PTN)?
How does the current ROE for Palatin Technologies, Inc. (PTN) compare to its historical average?